VRIO Analysis of Nabriva Therapeutics plc
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Nabriva Therapeutics plc will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Nabriva Therapeutics plc VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Nabriva Therapeutics plc VRIO Analysis shows that the financial resources of Nabriva Therapeutics plc are highly valuable as these help in investing into external opportunities that arise. These also help Nabriva Therapeutics plc in combating external threats.
- According to the VRIO Analysis of Nabriva Therapeutics plc, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Nabriva Therapeutics plc VRIO Analysis shows that Nabriva Therapeutics plc's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Nabriva Therapeutics plc's products.
- According to the VRIO Analysis of Nabriva Therapeutics plc, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Nabriva Therapeutics plc. These patents also provide Nabriva Therapeutics plc with licensing revenue when it licenses these patents out to other manufacturers.
- The Nabriva Therapeutics plc VRIO Analysis shows that Nabriva Therapeutics plc’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Nabriva Therapeutics plc. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Nabriva Therapeutics plc, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Nabriva Therapeutics plc VRIO Analysis shows that the research and development at Nabriva Therapeutics plc is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Nabriva Therapeutics plc. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Nabriva Therapeutics plc are found to be rare according to the VRIO Analysis of Nabriva Therapeutics plc. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Nabriva Therapeutics plc VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Nabriva Therapeutics plc and inhibit competitive advantage. This means that the local food products result in competitive parity for Nabriva Therapeutics plc. As this resource is valuable, Nabriva Therapeutics plc can still make use of this resource.
- The employees of Nabriva Therapeutics plc are a rare resource as identified by the VRIO Analysis of Nabriva Therapeutics plc. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Nabriva Therapeutics plc are a rare resource as identified by the Nabriva Therapeutics plc VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Nabriva Therapeutics plc to use them without interference from the competition.
- The distribution network of Nabriva Therapeutics plc is a rare resource as identified by the VRIO Analysis of Nabriva Therapeutics plc. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Nabriva Therapeutics plc. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Nabriva Therapeutics plc are costly to imitate as identified by the Nabriva Therapeutics plc VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Nabriva Therapeutics plc. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Nabriva Therapeutics plc provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Nabriva Therapeutics plc are also not costly to imitate as identified by the Nabriva Therapeutics plc VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Nabriva Therapeutics plc by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Nabriva Therapeutics plc a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Nabriva Therapeutics plc are very difficult to imitate as identified by the VRIO Analysis of Nabriva Therapeutics plc. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Nabriva Therapeutics plc is also very costly to imitate by competition as identified by the Nabriva Therapeutics plc VRIO Analysis. This has been developed over the years gradually by Nabriva Therapeutics plc. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Nabriva Therapeutics plc are organised to capture value as identified by the VRIO Analysis of Nabriva Therapeutics plc. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Nabriva Therapeutics plc.
- The Patents of Nabriva Therapeutics plc are not well organised as identified by the Nabriva Therapeutics plc VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Nabriva Therapeutics plc starts selling patented products before the patents expire.
- The distribution network of Nabriva Therapeutics plc is organised as identified by the VRIO Analysis of Nabriva Therapeutics plc. Nabriva Therapeutics plc uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Nabriva Therapeutics plc.
From the VRIO Analysis of Nabriva Therapeutics plc, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Nabriva Therapeutics plc is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Jolie Cham
5.0
Is this true well defined work with affordable prices? Yes! This service was proved to be the right workmate for me. Will be the most visiting customer soon.
Mansi Joshi
5.0
The due date of submission was just two days away and I was about to flunk from Information Technology. It is such a generous service that it didn’t demand extra charges for a tight deadline and issued me work under 28 hours. If someone is in the situation as I was, this service is helpful for them
Jazmin Daniel
5.0
There is nothing to complain about this service but to appreciate it and suggest to other students to hire this service.
Donald Raymond
5.0
The paper was completed within the desired time. I really appreciate this assignment writing service. Grateful!
Next Articles
- Naked Brand Group Limited Vrio Analysis
- NanoVibronix, Inc. Vrio Analysis
- Nasdaq, Inc. Vrio Analysis
- Nathan's Famous, Inc. Vrio Analysis
- National Energy Services Reunited Corp. Vrio Analysis
- National General Holdings Corp Vrio Analysis
- National Holdings Corporation Vrio Analysis
- National Security Group, Inc. Vrio Analysis
- National Vision Holdings, Inc. Vrio Analysis
- Nature's Sunshine Products, Inc. Vrio Analysis
Previous Articles
- MYnd Analytics, Inc. Vrio Analysis
- MVB Financial Corp. Vrio Analysis
- Mustang Bio, Inc. Vrio Analysis
- Mudrick Capital Acquisition Corporation Vrio Analysis
- MTech Acquisition Corp. Vrio Analysis
- Mr. Cooper Group Inc. Vrio Analysis
- Moxian, Inc. Vrio Analysis
- Motus GI Holdings, Inc. Vrio Analysis
- MorphoSys AG Vrio Analysis
- Monroe Capital Corporation Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!